BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24496455)

  • 1. Effect of oral anticoagulants on the outcome of faecal immunochemical test.
    Bujanda L; Sarasqueta C; Lanas Á; Quintero E; Cubiella J; Hernandez V; Morillas JD; Perez-Fernández T; Salas D; Andreu M; Carballo F; Bessa X; Portillo I; Jover R; Balaguer F; Cosme A; Castells A;
    Br J Cancer; 2014 Mar; 110(5):1334-7. PubMed ID: 24496455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening.
    Randel KR; Botteri E; Romstad KMK; Frigstad SO; Bretthauer M; Hoff G; de Lange T; Holme Ø
    Gastroenterology; 2019 May; 156(6):1642-1649.e1. PubMed ID: 30689972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Direct Oral Anticoagulants, Warfarin, Aspirin and Thienopyridine on the Performance of Immunochemical, Faecal, Occult Blood Tests.
    Niikura R; Yamada A; Fujishiro M; Tanaka K; Matsuda K; Saito Y; Ohtsuka K; Oda I; Katada C; Kato M; Kida M; Kobayashi K; Hoteya S; Horimatsu T; Kodashima S; Matsuda T; Muto M; Yamamoto H; Ryozawa S; Iwakiri R; Kutsumi H; Miyata H; Kato M; Haruma K; Fujimoto K; Uemura N; Kaminishi M; Shinozaki T; Tajiri H; Koike K
    Digestion; 2019; 100(2):117-126. PubMed ID: 30408803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test.
    Bujanda L; Lanas Á; Quintero E; Castells A; Sarasqueta C; Cubiella J; Hernandez V; Morillas JD; Perez-Fernández T; Salas D; Andreu M; Carballo F; Bessa X; Cosme A; Jover R;
    Mayo Clin Proc; 2013 Jul; 88(7):683-9. PubMed ID: 23751980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold.
    Young GP; Woodman RJ; Symonds E
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32994195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
    Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
    Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
    Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
    Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic screening for colorectal neoplasia in Singapore using faecal immunochemical occult blood test.
    Tan WS; Tang CL; Koo WH
    Singapore Med J; 2013 Apr; 54(4):220-3. PubMed ID: 23624450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
    Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
    Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
    Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
    Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the OC Sensor
    Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
    Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
    Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
    Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate.
    Blom J; Löwbeer C; Elfström KM; Sventelius M; Öhman D; Saraste D; Törnberg S
    J Med Screen; 2019 Jun; 26(2):92-97. PubMed ID: 30336730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.
    Fraser CG; Digby J; McDonald PJ; Strachan JA; Carey FA; Steele RJ
    J Med Screen; 2012 Mar; 19(1):8-13. PubMed ID: 22156144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative immunochemical fecal occult blood test for colorectal neoplasia.
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Ann Intern Med; 2007 Feb; 146(4):244-55. PubMed ID: 17310048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.
    Nieuwenburg SAV; Vuik FER; Kruip MJHA; Kuipers EJ; Spaander MCW
    Gut; 2019 May; 68(5):866-872. PubMed ID: 29871970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.